Vaccines and Related Biological Products Advisory Committee - 10/22/2020 - YouTube
A public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.
Steven Pergam, M.D., M.P.H.
Seattle Cancer care Alliance
"My question is, I know that
enrollment has been difficult in high-risk groups,
particularly the racial minorities.
And there's no specification about including
the appropriate number in the EUA specifically that I
could find that suggest that it would be equal numbers
based on what the trials should look like. And I'm
concerned that if an EUA's put forward without adequate
enrollment in those particular racial minorities that,
that might be seen in a negative light. So I'm curious
how that was decided and is there any thought about
modifying that specifically?"